Josh Trent is named as a lobbyist on federal disclosure filings for 6 clients through Leavitt Partners, LLC. The most recent filing naming them posted in October 2026. Issues reported include Health Issues.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| ORCHARD THERAPEUTICS NORTH AMERICA | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| GENOMIC ANSWERS FOR CHILDRENS HEALTH ALLIANCE (GACHA) | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| SAVE RARE TREATMENTS TASK FORCE | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| SICKLE CELL DISEASE PARTNERSHIP | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| 340B WORKING TABLE | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| THE DUAL ELIGIBLE COALITION | LEAVITT PARTNERS, LLC | Q3 2026 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 6 | 1 |
| 2025 | 5 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Josh Trent. See the Capitol Clarity rankings and method.